Markus Steinfath Selected Research

Culture Media

1/2017	Doxycycline protects human intestinal cells from hypoxia/reoxygenation injury: Implications from an in-vitro hypoxia model.
3/2014	Culture media from hypoxia conditioned endothelial cells protect human intestinal cells from hypoxia/reoxygenation injury.
2/2012	Serum from patients undergoing remote ischemic preconditioning protects cultured human intestinal cells from hypoxia-induced damage: involvement of matrixmetalloproteinase-2 and -9.
2/2010	Hypoxia-induced cell damage is reduced by mild hypothermia and postconditioning with catalase in-vitro: application of an enzyme based oxygen deficiency system.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Markus Steinfath Research Topics

Disease

11	Hypoxia (Hypoxemia) 10/2020 - 02/2010
5	Heart Arrest (Cardiac Arrest) 01/2021 - 10/2006
4	Wounds and Injuries (Trauma) 01/2018 - 09/2010
4	Hypotension (Low Blood Pressure) 09/2010 - 06/2005
4	Hemorrhage 07/2007 - 02/2006
3	Ischemia 12/2017 - 01/2014
3	Hypothermia 01/2017 - 02/2010
3	Shock 08/2011 - 05/2009
3	Hemorrhagic Shock 03/2007 - 02/2006
2	Edema (Dropsy) 01/2015 - 01/2015
2	Critical Illness (Critically Ill) 01/2011 - 01/2011
2	Ventricular Fibrillation 10/2008 - 11/2007
2	Contracture 10/2002 - 08/2002
2	Malignant Hyperthermia 10/2002 - 08/2002
1	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 12/2016
1	Cardiac Arrhythmias (Arrythmia) 01/2015
1	Pain (Aches) 01/2015
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 01/2014
1	Hyperalgesia 01/2013
1	Colonic Neoplasms (Colon Cancer) 04/2012
1	Neoplasms (Cancer) 04/2012
1	Carcinoma (Carcinomatosis) 04/2012
1	Hypovolemia 08/2011
1	Myocardial Infarction 09/2010
1	Fibrosarcoma 02/2010
1	Pneumoperitoneum 02/2009

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2019 - 02/2010
6	Starch (Cornstarch)IBA 09/2010 - 02/2006
5	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2019 - 02/2010
5	Caspase 3 (Caspase-3)IBA 01/2019 - 02/2012
5	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2011 - 02/2006
4	Culture MediaIBA 01/2017 - 02/2010
4	Oxygen (Dioxygen)IBA 04/2012 - 10/2006
4	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 09/2010 - 10/2006
4	Arginine Vasopressin (Argipressin)IBA 05/2009 - 02/2006
4	SolutionsIBA 05/2009 - 02/2006
3	Lactic Acid (Lactate)FDA LinkGeneric 01/2021 - 01/2015
3	EnzymesIBA 01/2017 - 02/2010
3	CatalaseIBA 11/2013 - 02/2010
2	Matrix Metalloproteinases (MMPs)IBA 01/2019 - 02/2012
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2019 - 12/2016
2	Propofol (Diprivan)FDA LinkGeneric 01/2018 - 09/2010
2	ProteomeIBA 01/2017 - 12/2016
2	2-iminobiotinIBA 01/2017 - 12/2016
2	Phenobarbital (Luminal)FDA Link 01/2015 - 01/2015
2	Galactose (Galactopyranose)FDA LinkGeneric 01/2015 - 01/2015
2	Analgesics (Analgesic Drugs)IBA 01/2015 - 04/2012
2	fluorescein isothiocyanate dextranIBA 01/2015 - 01/2015
2	Anesthetics (Anesthetic Agents)IBA 01/2014 - 10/2010
2	Sevoflurane (Ultane)FDA LinkGeneric 01/2014 - 10/2010
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2010 - 02/2010
2	Vasopressins (Vasopressin)IBA 11/2007 - 03/2007
2	Colloids (Colloid)IBA 10/2006 - 04/2006
2	Halothane (Fluothane)FDA Link 10/2002 - 08/2002
2	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 10/2002 - 08/2002
2	Caffeine (No Doz)FDA LinkGeneric 10/2002 - 08/2002
1	CytokinesIBA 10/2020
1	Malondialdehyde (Propanedial)IBA 01/2019
1	XenonIBA 12/2017
1	Doxycycline (Periostat)FDA LinkGeneric 01/2017
1	Neuroprotective AgentsIBA 12/2016
1	Biotin (Vitamin H)FDA Link 12/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2016
1	CatecholaminesIBA 01/2015
1	Pyruvic Acid (Pyruvate)IBA 01/2015
1	GelatinasesIBA 03/2014
1	Conditioned Culture MediaIBA 03/2014
1	Glucose OxidaseIBA 11/2013
1	Lactate Dehydrogenase 5IBA 11/2013
1	Glucose (Dextrose)FDA LinkGeneric 11/2013
1	Biomarkers (Surrogate Marker)IBA 11/2013
1	NMDA receptor A1IBA 01/2013
1	Morphine (MS Contin)FDA LinkGeneric 01/2013
1	Ketamine FDA LinkGeneric 01/2013
1	RNA (Ribonucleic Acid)IBA 01/2013
1	Messenger RNA (mRNA)IBA 01/2013
1	EsketamineIBA 01/2013
1	Clonidine (ST 155)FDA LinkGeneric 01/2013
1	Opioid Analgesics (Opioids)IBA 01/2013
1	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 04/2012
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2012
1	Phosphotransferases (Kinase)IBA 02/2012
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 02/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2010
1	InterleukinsIBA 09/2010
1	Hydroxyl RadicalIBA 02/2009
1	Epinephrine (Adrenaline)FDA LinkGeneric 11/2007

Therapy/Procedure

8	Therapeutics 01/2021 - 04/2006
8	Resuscitation 12/2011 - 02/2006
4	Cardiopulmonary Resuscitation (CPR) 08/2011 - 10/2006
2	Anesthesia 01/2018 - 12/2017
2	Spinal Anesthesia 03/2006 - 06/2005
1	Early Goal-Directed Therapy 01/2021
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 12/2017
1	Operative Surgical Procedures 05/2014
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 04/2014
1	Analgesia 01/2013
1	Fluid Therapy (Oral Rehydration Therapy) 08/2011
1	Critical Care (Surgical Intensive Care) 01/2011
1	Enteral Nutrition (Feeding, Tube) 01/2011